Sogroya यूरोपीय संघ - लातवियाई - EMA (European Medicines Agency)

sogroya

novo nordisk a/s - somapacitan - izaugsme - hipofīzes un hipotalāma hormoni un analogi - sogroya is indicated for the replacement of endogenous growth hormone (gh) in children  aged 3  years and above, and adolescents with growth failure due to growth hormone deficiency (paediatric ghd), and in adults with growth hormone deficiency (adult ghd).

Ngenla यूरोपीय संघ - लातवियाई - EMA (European Medicines Agency)

ngenla

pfizer europe ma eeig - somatrogon - growth and development - hipofīzes un hipotalāma hormoni un to analogi - indicated for the long-term treatment of paediatric patients with growth disturbance due to insufficient secretion of growth hormone.

Orgovyx यूरोपीय संघ - लातवियाई - EMA (European Medicines Agency)

orgovyx

accord healthcare s.l.u. - relugolix - prostatas audzēji - endokrīnā terapija - orgovyx is indicated for the treatment of adult patients with advanced hormone-sensitive prostate cancer.

Camcevi यूरोपीय संघ - लातवियाई - EMA (European Medicines Agency)

camcevi

accord healthcare s.l.u. - leuprorelin mesilate - prostatas audzēji - endokrīnā terapija - camcevi is indicated for the treatment of hormone dependent advanced prostate cancer and for the treatment of high-risk localised and locally advanced hormone dependent prostate cancer in combination with radiotherapy.

Ganirelix Theramex 0,25 mg/0,5 ml šķīdums injekcijām pilnšļircē लातविया - लातवियाई - Zāļu valsts aģentūra

ganirelix theramex 0,25 mg/0,5 ml šķīdums injekcijām pilnšļircē

theramex ireland limited, ireland - ganirelikss - Šķīdums injekcijām pilnšļircē - 0,25 mg/0,5 ml

Targretin यूरोपीय संघ - लातवियाई - EMA (European Medicines Agency)

targretin

eisai gmbh - bexarotene - limfomas, t-šūnu, Ādas - antineoplastiski līdzekļi - targretin kapsulas ir paredzētas, lai ārstētu ādas progresēšanu progresējošas ādas t-šūnu limfomas (ctcl) pacientiem, kuri ir rezistenti vismaz vienai sistēmiskai ārstēšanai.